Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.
about
Apolipoprotein(a) acts as a chemorepellent to human vascular smooth muscle cells via integrin αVβ3 and RhoA/ROCK-mediated mechanismsVariation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) productionRelationship between apolipoprotein(a) size polymorphism and coronary heart disease in overweight subjectsInsulin sensitivity and Lp(alpha) concentrations in normoglycemic offspring of type 2 diabetic parentsAssociations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the Atherosclerosis Risk in Communities (ARIC) StudyLipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biologyRelationship of lipoprotein(a) to variables of coagulation in hypertensive subjects.Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective.Prevalence of microalbuminuria, lipoprotein (a) and coronary artery disease in the lipid clinicMutagenesis of the human apolipoprotein B gene in a yeast artificial chromosome reveals the site of attachment for apolipoprotein(a)Genetic basis of lipoprotein disorders.Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a)Lipoprotein(a) oxidation and autoantibodies: a new path in atherothrombosis.Behavioral health mediators of the link between posttraumatic stress disorder and dyslipidemia.Proposed mechanisms for binding of apo[a] kringle type 9 to apo B-100 in human lipoprotein[a].The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rateCaloric restriction: powerful protection for the aging heart and vasculature.Atherosclerosis and autoimmunity.Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresisThe role of risk factors in the development of atherosclerosis.Assessment of the 9p21.3 locus in severity of coronary artery disease in the presence and absence of type 2 diabetes.Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogenEnigmatic role of lipoprotein(a) in cardiovascular disease.New paradigms in preventive cardiology: unconventional coronary risk factorsLipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease.Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease.Expressed hypervariable polymorphism of apolipoprotein (a).Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.Hormonal regulation of serum Lp (a) levels. Opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinomaApolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrationsThe Lipid Parameters and Lipoprotein(a) Excess in Hashimoto Thyroiditis.Cholesterol and lipoproteins: beyond atherogenesis.Recent advances in lipoprotein and atherosclerosis research at Baylor College of Medicine. Apolipoprotein B, lipoprotein[a], and transplantation arteriopathyHypoascorbemia induces atherosclerosis and vascular deposition of lipoprotein(a) in transgenic miceLipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.Lipoprotein(a): an elusive cardiovascular risk factorLp(a)-cholesterol is associated with HDL-cholesterol in overweight and obese African American children and is not an independent risk factor for CVD.Immunohistochemical distribution of lipoprotein epitopes in xanthomata from patients with familial hypercholesterolemia.Genes and atherosclerosis: at the origin of the predisposition.
P2860
Q24294266-F3636A96-A595-4049-8C09-49F5A668C596Q24601964-514EEC90-08E0-4DAA-A106-0DD0D82E5549Q24792333-29AEA987-609C-4F39-8999-8A29257DEA2CQ24796609-ACEA8A69-7E3D-4EFC-A8B3-5314D5C0AA74Q28254321-D06DD6FA-9FA8-4A1F-A34F-601CBA7B1059Q30242031-018C78D1-0AF4-4481-9C07-C3D644401EE4Q32056571-89AA4924-683E-418D-8D25-D9E8BE9A8EE5Q33306319-B49D0F9C-777F-4C4E-BC84-AAA2C934DEE7Q33608889-428EDC92-45CA-4DC4-82D7-14EB649E4F73Q33822162-3F61E537-4531-4009-93A5-0095068A4E5AQ33847743-AA57B983-0E9D-4639-BA82-3DA8BA88923EQ33888645-9911F5F4-026C-4741-9691-2203AAEFEF00Q33915460-5FA20B6A-33D0-4570-A638-DA21B3CF86B5Q33997587-39E31F84-B2A9-42C2-80FF-96E49E729CD9Q34092208-B8840E02-50B7-4720-939C-AD78BBC70F7FQ34154477-D3A793BD-EED2-4F1E-96DE-3D074A5A883EQ34207941-6966EDFF-C91F-4E66-A9DC-CDA547DDC78AQ34243799-B8BCD84D-FCD8-48E1-B988-AC2AEB1349E2Q34265255-803A8D15-79FD-4235-8D61-E4BB5DCE4C62Q34447107-60C716A2-394C-48E0-B0F5-DE010AC42098Q34560074-6D904FED-5AC9-44C6-B552-ACFDFB465EEEQ34622938-B5E600DD-BDE1-4E8E-A4E1-9B8693ACD999Q34786504-7AECCBFA-BE88-44FA-A767-45AFF93DB8F0Q35052188-CF6D8C71-D629-4647-AFB3-D1117519E1CCQ35171679-291BFF9F-975D-4F0B-B9D1-2A2071457AE3Q35189645-407CEE75-FB8E-4226-95E8-197CE7A6CAFCQ35196427-9C71B59F-0E77-484D-8A50-79B0A5DDC6B3Q35197067-3CBB0C58-920E-40FC-8688-9304006999AFQ35599857-6FF800F4-CE6C-4CA5-84B4-72D2C7EB6C1AQ35600471-3218AE12-8E1E-4ED3-A7FC-3A1A65D6169FQ35603379-325A1536-4C10-4FC7-9B5F-40EF55DCA14BQ35612696-5D384230-6B43-4F48-964B-FC888F268251Q35633523-0224F156-FEF6-4EF0-9BFC-3673FD2EADA7Q35651981-8A6218D3-697B-40E1-B4EC-114E6423F121Q35659454-52EFEF41-60EA-4A32-B7E4-D8DB1C2D00D0Q35737842-39DE9FED-99DB-436C-B2F1-AC40F7F89DDBQ35746190-855C823F-148B-4A0B-B2B0-E8C84DF8D7E2Q35799926-3DADBA68-611F-4DFE-96E7-201B14B36CC4Q35831887-52E1985B-4931-4F17-B745-144BF3DAEBF8Q36107754-69D5E8DB-41D1-4240-AB94-44855AA9B5D5
P2860
Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh-hant
name
Association of levels of lipop ...... ase documented by angiography.
@en
Association of levels of lipop ...... ase documented by angiography.
@nl
type
label
Association of levels of lipop ...... ase documented by angiography.
@en
Association of levels of lipop ...... ase documented by angiography.
@nl
prefLabel
Association of levels of lipop ...... ase documented by angiography.
@en
Association of levels of lipop ...... ase documented by angiography.
@nl
P2093
P356
P1433
P1476
Association of levels of lipop ...... ase documented by angiography.
@en
P2093
P304
P356
10.1161/01.CIR.74.4.758
P407
P577
1986-10-01T00:00:00Z